Clover Health Investments Corp (CLOV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Clover Health Investments Corp (CLOV) has a cash flow conversion efficiency ratio of 0.318x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($107.89 Million) by net assets ($339.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Clover Health Investments Corp to measure how much of total assets are equity-financed.
Clover Health Investments Corp - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Clover Health Investments Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Clover Health Investments Corp (CLOV) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Clover Health Investments Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clover Health Investments Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Suning Commerce Group Co Ltd
SHE:002024
|
0.016x |
|
Xinhuanet Co Ltd
SHG:603888
|
0.034x |
|
Citic Offshore Helicopter Co Ltd
SHE:000099
|
0.009x |
|
LuxNet
TWO:4979
|
0.097x |
|
IMAX Corporation
F:IMA
|
0.009x |
|
Elvalhalcor Hellenic Copper and Aluminium Industry S.A
AT:ELHA
|
0.104x |
|
Jiangsu Zhangjiagang Rural Commercial Bank Co Ltd
SHE:002839
|
0.253x |
|
Global Partners LP
NYSE:GLP
|
-0.114x |
Annual Cash Flow Conversion Efficiency for Clover Health Investments Corp (2018–2025)
The table below shows the annual cash flow conversion efficiency of Clover Health Investments Corp from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Clover Health Investments Corp stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $308.70 Million | $-66.93 Million | -0.217x | -312.28% |
| 2024-12-31 | $341.14 Million | $34.84 Million | 0.102x | +125.25% |
| 2023-12-31 | $286.39 Million | $-115.87 Million | -0.405x | +29.19% |
| 2022-12-31 | $356.89 Million | $-203.93 Million | -0.571x | -9.15% |
| 2021-12-31 | $539.32 Million | $-282.33 Million | -0.523x | -370.89% |
| 2020-12-31 | $-613.19 Million | $-118.50 Million | 0.193x | -100.00% |
| 2019-12-31 | $-17.63K | $-159.88 Million | 9067.835x | +324244.80% |
| 2018-12-31 | $-54.83 Million | $-153.28 Million | 2.796x | -- |
About Clover Health Investments Corp
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Del… Read more